XOMA Royalty (XOMA) Free Cash Flow (2010 - 2026)
XOMA Royalty (XOMA) reported Free Cash Flow of $6.1 million for Q1 2026, up 178.48% on a YoY basis from $2.2 million in Q1 2025, and up 211.27% sequentially from -$5.5 million in Q4 2025.
XOMA Royalty (XOMA) Free Cash Flow (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Free Cash Flow data on file, last reported at $6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 178.48% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 207.33% YoY), and the FY2025 full-year result was $2.9 million, up 120.85% from the prior year.
- Free Cash Flow grew to $6.1 million in Q1 2026, from -$5.5 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $6.5 million in Q2 2025 to a low of -$8.6 million in Q3 2024.
- A 5-year average of -$2.2 million and a median of -$3.8 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 388.01% in 2023 and surged 178.48% in 2026, its largest moves.
- Tracing XOMA's Free Cash Flow over 5 years: stood at -$3.9 million in 2022, then declined by 0.95% to -$3.9 million in 2023, then climbed by 26.0% to -$2.9 million in 2024, then tumbled by 89.3% to -$5.5 million in 2025, then jumped by 211.27% to $6.1 million in 2026.
- Business Quant data shows XOMA's Free Cash Flow at $6.1 million in Q1 2026, -$5.5 million in Q4 2025, and $6.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 6.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.12 Mn |
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Sep 30, 2024 | -8.63 Mn |
| Sep 30, 2024 | -8.63 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Mar 31, 2024 | -4.96 Mn |
| Mar 31, 2024 | -4.96 Mn |
| Dec 31, 2023 | -3.93 Mn |
| Dec 31, 2023 | -3.93 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Sep 30, 2023 | -2.10 Mn |